Lieber


Ten Stories That Shaped 2021

At Harvard, 2021 was a year marked by change. The school’s long-awaited return to in-person operations injected new life into a campus that had been left dormant for over a year by Covid-19. And in an unexpected shift, the University announced its intention to divest its endowment from fossil fuels after a decade of public pressure. Separately, faculty controversies — including a federal conviction and a high-profile departure — ignited debates that rippled across academia. Below, The Crimson looks back at the 10 stories that shaped the last year at Harvard.


Lieber Told FBI He ‘Wasn’t Completely Transparent’ in Prior Interview with Federal Investigators

Harvard professor Charles M. Lieber told the FBI in January 2020 that he “wasn’t completely transparent” in a separate interview with federal investigators two years prior, according to video of an interrogation presented in court by government prosecutors on Friday.


Attorneys Spar Over Documents Recovered in FBI Raids During Third Day of Lieber Trial

Defense attorneys representing Harvard professor Charles M. Lieber, who is facing trial for allegedly lying to federal investigators about his ties to China, sparred with prosecutors on Thursday over the evidentiary relevance of documents obtained during raids of the prominent chemist’s home and office.


As Trial Begins, Lawyers for Harvard Professor Charles Lieber Say He Did Not Conceal Ties to China

Lawyers for Harvard professor Charles M. Lieber, who is accused of lying to federal investigators about his ties to China, mounted a dramatic defense of the renowned chemist in federal court Wednesday, calling the government’s proof against him “mangled” and “misguided.”


DAY 1

Former Harvard Chemistry chair Charles M. Lieber (left) and his lawyer, Marc Mukasey, exit the John J. Moakley United States Courthouse in Boston on Tuesday.


Experts Say Lieber Trial Could Decide Fate of DOJ’s China Initiative

As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.


1-10 of 10